Oral Oncology
Volume 46, Issue 1 , Pages e2-e3 , January 2010

The need to reassess studies on detection of potentially premalignant and malignant oral lesions

Received 29 September 2009 ,Accepted 14 October 2009.

References 

  1. Fischer DJ, Epstein JB, Morton TH, Schwartz SM. Reliability of histologic diagnosis of clinically normal intraoral tissue adjacent to clinically suspicious lesions in former upper aerodigestive tract cancer patients. Oral Oncol. 2005;41(5):489–496
  2. Slater LJ. Comment on “analysis of oral lesion biopsies identified and evaluated by visual examination, chemiluminescence and toluidine blue” [Epstein JB et al. Oral Oncol 2008;44(6):538–44]. Oral Oncol. 2009;45(3):296;[author reply 297–8. Epub 2009 Jan 14. Comment on: Oral Oncol 2008;44(6):538–44]
  3. Epstein JB, Silverman S, Sciubba J, Bride M. Reply: defining the risk of premalignant lesions. Oral Oncol. 2009;45(3):297–302
  4. Wenig BM. Squamous cell carcinoma of the upper aerodigestive tract: precursors and problematic variant. Mod Pathol. 2002;15(3):229–254
  5. Wenig BM. Keratinizing dysplasia of the upper aerodigestive tract. Pathol Case Rev. 2008;13(1):9–16
  6. Mashberg A, Samit A. Early diagnosis of asymptomatic oral and oropharyngeal squamous cancers. CA Cancer J Clin. 1995;45(6):328–351
  7. Fischer DJ, Epstein JB, Morton TH, Schwartz SM. Inter-observer reliability in the histopathologic diagnosis of oral premalignant and malignant lesions. J Oral Pathol Med. 2004;33(2):65–70
  8. Partridge M, Li SR, Pateromichelakis S, et al. Detection of minimal residual cancer to investigate why oral tumors recur despite seemingly adequate treatment. Clin Cancer Res. 2000;6(7):2718–2725
  9. Braakhuis BJ, Tabor MP, Kummer JA, et al. A genetic explanation of slaughter’s concept of field cancerisation: evidence and clinical implications. Cancer Res. 2003;63(8):1727–1730
  10. Epstein JB, Zhang L, Rosin M. Advances in the diagnosis of oral premalignant and malignant lesions. J Can Dent Assoc. 2002;68(10):17–21
  11. Hodgson DR, Foy CA, Partridge M, et al. Development of a facile fluorescent assay for the detection of 80 mutations within the p53 gene. Mol Med. 2002;8(5):227–237
  12. Patton LL, Epstein JB, Kerr AR. Adjuncts for oral cancer examination and lesion diagnosis: a systematic review of literature. J Am Dent Assoc. 2008;139(7):896–905
  13. Guo Z, Yamaguchi K, Sanchez-Cespedes M, et al. Allelic losses in oratest-directed biopsies of patients with prior upper aerodigestive tract malignancies. Clin Cancer Res. 2001;7(7):1963–1968
  14. Epstein JB, Zhang L, Poh C, et al. Increased allelic loss in toluidine blue positive oral malignant lesions. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2003;95(1):45–50
  15. Zhang L, Williams M, Poh CF, et al. Toluidine blue staining identifies high-risk primary oral premalignant lesions with poor outcome. Cancer Res. 2005;65(17):8017–8021

PII: S1368-8375(09)00942-7

doi: 10.1016/j.oraloncology.2009.10.006

Oral Oncology
Volume 46, Issue 1 , Pages e2-e3 , January 2010

Article Tools